U.S. joins whistleblower lawsuit against Valeant's Salix unit
NEW YORK, June 9 (Reuters) - The U.S. government has joined a whistleblower lawsuit accusing the Salix unit of Valeant Pharmaceuticals International Inc of paying illegal kickbacks to doctors to induce them to prescribe its products, and submitting false claims for the products to Medicaid and Medicare.
According to a filing made public on Thursday in the U.S. District Court in Manhattan, the alleged improper conduct occurred from January 2009 to December 2013, predating Valeant's purchase of Salix last year.
(Reporting by Jonathan Stempel in New York; Editing by Tom Brown)
© Thomson Reuters 2017 All rights reserved.